https://dmoginhibitor.com/is-o....ptometry-ready-regar
Deep Sequence achieved powerful when it comes to prediction of exudation within a few months (0.96 ± 0.02 AUCROC) and within 21 months (0.97 ± 0.02 AUCROC) on cross-validation. Training the recommended design on this medical trial dataset and testing it on an external real-world medical dataset revealed high end when it comes to forecast within 3-months (0.82 AUCROC) but an obvious decline in overall performance for the prediction within 21-months (0.68 AUCROC). While overall performance differences at l
Like
Comment
Share
